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Introduction
Microscopic transsphenoidal surgery is 
a widely accepted and highly effective therapy for 
pituitary adenomas [1], [2]. In the last decade, more 
centers have converted from microscopic to completely 
endoscopic transsphenoidal approach, suggesting that 
this technique provides more complete tumor resection 
and/or reduction, controlling the usual complications at 
the same time [3], [4]. However, only a few worldwide 
multicentric studies exist to document the results of this 
procedure.
This study is a comparative overview of both 
of the above-mentioned surgical procedures in our 
institution for our population. It presents our experience 
in the treatment of pituitary adenomas, comparing 
the two procedures to each other. At the same time, 
an analogous comparison is made of the outcome of 
treatment in our institution of patients who have been 
treated with complete endoscopic transsphenoidal 
pituitary surgery versus the results of patients treated 
with microscopic technique. Its purpose is to establish 
and implement a procedure that will provide safer, more 
effective treatment with a better cost-benefit index.
Diagnostic procedures, clinical evaluation
Assessment of patients undergoing surgical 
treatment of pituitary adenomas begins with a 
multidisciplinary evaluation of subjective symptoms, 
objective clinical signs, initially performed by a primary 
care physician, neurosurgeon, endocrinologist, 
ophthalmologist, or neurologist. Anatomical and 
functional assessment of the pituitary gland is of great 
importance. A neurosurgeon and an endocrinologist 
evaluate the pituitary lesion. Indications for surgical 
treatment of pituitary adenomas are based on 
functional symptoms, objective clinical signs, computed 
tomography, and magnetic resonance imaging (MRI) 
findings [5], [6].
Ophthalmic symptoms are manifested by 
contact or compression of the chiasm and anterior 
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visual pathways with the lesion [7]. Oculomotor nerve 
palsy is manifested by penetration and compression of 
the lesion in the cavernous sinus [8], [9].
Extensive growth of the lesion by suprasellar 
progression, compression of the third ventricle, 
compromising the foramen of Monroe, and the liquid 
flux can potentially cause obstructive hydrocephalus.
Initial symptoms and signs may be discrete latent 
and are evidenced by sophisticated endocrinological 
functional tests, but also ophthalmological, and 
neuroradiological findings.
Surgical treatment of primary adenomas needs 
to be critically compared to other treatment options 
such as medical therapy, and sometimes radiotherapy 
and/or gamma knife, which is often performed as an 
alternative procedure. An indication for operative 
treatment is either tumor recurrence or progressive 
growth in a residual tumor [10].
Study design
This study is a retrospective-prospective 
randomized clinical trial, evaluating both treatment 
technologies. The randomization is performed with the 
patient’s free choice of the operative team.
In the period of 2011–2018, 85 patients 
were treated, respectively, with microscopic and/or 
endoscopic-assisted technology, as well as endoscopic 
transsphenoidal resection of pituitary adenomas, that 
is now the subject of this study. They are processed 
with inclusive and exclusive criteria. Patients were 
randomized into two groups. The first group is 
patients treated with transsphenoidal microscopic and 
microscopically assisted hypophysectomy. The second 
group includes patients surgically treated with a fully 
transsphenoidal endoscopic technique.
The subject of this study will be patients with a 
recorded lesion, pituitary adenomas, hormonally active 
as well as hormonally inactive, or dysfunctional. A 
retrospective review of patient records, post-operative, 
clinical, and outpatient data was used, and prospective 
patients will be used to determine the outcome of 
treatment.
The first group, the majority of treated patients 
were retrospectively analyzed, until 2014, treated 
with transsphenoidal microscopic and microscopically 
assisted hypophysectomy. The second group includes 
patients surgically treated with a fully transsphenoidal 
endoscopic technique.
There are several goals defined in this study: 
First, to determine the prevalence of pre-operative 
visual acuity affection; second, to determine the type 
of visual acuity; and third, to determine post-operative 
ophthalmologic status comparatively in both operating 
methods.
Materials and Methods
The study was conducted in the University Clinic 
of Neurosurgery at the Clinical Center Mother Teresa, 
Skopje, Macedonia. Designed as a retrospective-
prospective clinical trial, aiming to evaluate and 
compare both technologies in the period 2011-2018.
This study treated 85 patients, 46 of whom 
were treated with microscopic and/or endoscopic-
assisted microscopic resection and 39 patients treated 
only with endoscopic transsphenoidal resection of 
pituitary adenomas as the subject of this study. Initially 
treated patients were mainly treated with a microscopic 
transnasal technique as the only possible option in our 
institution until 2014.
The procurement of the necessary equipment 
and resources has opened the possibility for endoscopic 
assisted and fully endoscopic technology for resection 
of pituitary adenomas.
Inclusion criteria
The following criteria were included in the 
study:
• Patients over 14 years of age of both sexes;
• Patients with clinically diagnosed adenomas;
• Patients with sellar lesions which, by 
configuration, volume and anatomic 
configuration without distortion, provide safe 
transsphenoidal resection;
• Patients with lesions in which the diaphragm of 
the sella is intact;
• Patients with invasive lesions, penetrating 
over the diaphragm of the sella, but with 
prior strategy and consent for double phase 
resection, the first of which is transnasal 
endoscopic approach;
• Patients with microadenomas with Cushing’s 
disease as life threatening; and
• Patients previously treated with transnasal 
transsphenoidal microscopic approach, 
and endoscopically assisted resection 
with diagnosed recurrence with clinical 
manifestation.
Exclusion criteria
The following criteria were excluded from the 
study:
• Patients under 14 years of age of both sexes;
• Patients with lesions with unfavorable 
anatomical configuration for safe resection 
along this corridor (close carotid artery, high 
suprasellar, parasellar tumor extension, 
cavernous sinus involvement...);
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• Patients with sellar lesions of other histological 
and etiopathogenic structure;
• Patients with microadenomas that are 
favorable for conservative treatment; and
• Patients with previous operative procedures 
across this corridor with reported complications 
and high risks.
Results
Neuroendoscopy is an impressive high-tech 
surgical procedure, with relaxed, comfortable 
accessibility, and simplicity, at the same time 
complemented by continuous expertise in continuous 
medical education and training, provided with improved 
field of vision, angle of view, brightness, bimanual 
manipulation, and better potential for manipulation in 
case of complications, ensuring marked improvement 
in the outcome of treating patients with hypophyseal 
adenomas.
Namely, with the implementation of 
neuroendoscopy in our institution, the expectations are 
that there will be a significant improvement and facilitation 
in the management of sellar pathology, in terms of 
volume of resection, i.e., less voluminous residual tumor, 
reduced risk for recurrence, general extended grace 
period in case of recurrence, improvement of hormonal 
status, reducing the risk of complications, shortening 
hospital treatment, or better cost-benefit index.
The results regarding pre-operative visual 
acuity in both patient groups are shown in Table 1. 
Results for the type of visual acuity in the two 
patient groups are shown in Table 2.
Table 1: Pre-operative visual acuity affection
Pre-operative visual acuity affection Total
No affection Affected visual acuity
Procedure
Microscopic
Count 12 34 46
% 26.1% 73.9% 100.0%
Endoscopic
Count 16 23 39
% 41.0% 59.0% 100.0%
Total
Count 28 57 85
% 32.9% 67.1% 100.0%
Table 2: Type of visual affection
Procedure Type of visual affection Total
Scotoma Hemianopsia Reduced 
acuity
Amblyopia Amaurosis Diplopia
Microscopic
Count 9 11 7 0 6 1 34
% 26.5% 32.4% 20.6% 0.0% 17.6% 2.9% 100.0%
Endoscopic
Count 1 6 8 5 3 0 23
% 4.3% 26.1% 34.8% 21.7% 13.0% 0.0% 100.0%
Total
Count 10 17 15 5 9 1 57
% 17.5% 29.8% 26.3% 8.8% 15.8% 1.8% 100.0%
In the group of 46 patients treated with microscopic 
transsphenoidal surgery, 12 (26.10%) patients were 
preoperatively unaffected and 34 (73.90%) patients 
were afflicted. In the group of 39 patients treated with 
endoscopic transsphenoidal approach, 16 (41.00%) 
patients were preoperatively without visual acuity 
affection and 23 (59.00%) patients had affected visual 
acuity.
For Pearson Chi-square = 2.13 and p > 0.05 
(p = 0.14), there was no significant difference between 
the two groups of patients in terms of pre-operative 
visual acuity.
Table 3: Post-operative ophthalmologic status in patients with 
pre-operative visual affection
Post-operative ophthalmologic status Total
Unchanged Partially  
improved
Significantly  
improved
Normalized
Procedure
Microscopic
Count 14 14 6 0 34
% 41.2% 41.2% 17.6% 0.0% 100.0%
Endoscopic
Count 0 2 14 7 23
% 0.0% 8.7% 60.9% 30.4% 100.0%
Total
Count 14 16 20 7 57
% 24.6% 28.1% 35.1% 12.3% 100.0%
In the group of 34 patients undergoing 
microscopic transsphenoidal surgery, the following 
results were obtained with regard to the type of visual 
acuity: 9 (26.50%) patients had visual field scotoma, 
11 (32.40%) patients had hemianopsia, 7 (20, 60% of 
patients had reduced acuity, 6 (17.60%) patients had 
amaurosis, and 1 (2.90%) patients had diplopia.
In the group of 23 patients treated with 
endoscopic transsphenoidal approach, the following 
results were obtained in terms of the type of visual 
acuity: 1 (4.30%) patients had visual field scotoma, 
6 (26.10%) patients had hemianopsia, 8 (34, 80% of 
patients had reduced acuity, 5 (21.70%) amblyopia, 
and 3 (13.00%) patients had amaurosis.
For Fisher’s exact test = 12.89 and p < 0.05 
(p = 0.015)/Monte Carlo Sig./0.012–0.018/there is 
a significant difference in the type of visual acuity in 
patients treated with both operating methods.
Results regarding post-operative 
ophthalmologic status in patients with pre-operative 
visual acuity treated with both operating methods are 
shown in Table 3.
Of the 34 patients treated with microscopic 
transversal surgery, in 14 (41.20%), the post-operative 
ophthalmologic status remained unchanged; in 
14 (41.20%), the post-operative ophthalmologic status 
partially improved; and in 6 (17.60%), the post-operative 
ophthalmologic status was significantly improved.
Of the 23 patients treated with endoscopic 
transsphenoidal approach, in 2 (8.70%), the post-
operative ophthalmologic status was partially improved; 
in 14 (60.90%), the post-operative ophthalmologic 
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status improved significantly; and in 7 (30.40%), the 
post-operative the ophthalmic operating status was 
normalized.
For Fisher’s exact test = 34.16 and p < 0.001 
(p = 0.000)/Monte Carlo Sig., there is a significant 
difference in post-operative ophthalmologic status in 
patients treated with both operating methods.
Discussion
Pituitary adenoma surgery has gradually 
evolved toward less invasive approaches, primarily 
the transsphenoidal corridor, with endoscopic 
technique. There has been more and more evidence 
that endoscopic surgery is a safe, minimally 
invasive alternative for the treatment of pituitary 
adenomas [11], [12], [13], [14], [15], [16]. Endoscopy 
is already expanding borders, eliminating surgical 
limitations, improving performance, primarily by 
improving visualization, lighting, and reliability, allowing 
removal of lesions that were inaccessible by prior 
technology and corridors. It is already clearly noted that 
the feature of minimal invasiveness significantly affects 
the positive outcomes and lowers the post-operative 
complications in endoscopic procedures compared to 
the microscopic approach [17].
The results of our meta-analysis clearly favor 
endoscopic technology for pituitary surgery compared to 
microscopic technique. The endoscopic approach was 
a significant improvement in the extend of resection, 
with a markedly reduced number and volume of lesion 
residues, and thus a reduced number and volume of 
recurrent adenomas, followed by shorter hospital stay/
treatment, less incidence of defects, and bleeding. 
Furthermore, there was a significant improvement in 
complications such as meningitis, cerebrospinal fluid 
(CSF) fistula, hypopituitarism, and diabetes mellitus.
Preoperatively, visual acuity is almost identical 
in both groups. Post-operative ophthalmologic 
examinations (ophthalmologic examination, visual 
acuity, perimetry, fundus, and VEP), by comparison, 
showed a significant difference.
Namely, of 34 patients with preoperatively 
affected visual acuity that was treated microscopically, 
14 remained unchanged, 14 had partial improvement, 
and 6 had significant benefit.
The group treated with the endoscopic 
approach reported improvement in almost all patients. 
In 2 patients, there was a partial improvement in 14 
significant improvements and in 7 patients, post-
operative normalization was achieved.
In addition, comparing cross-tabulation 
findings, volume of resection and post-operative 
ophthalmologic status in patients with pre-operative 
visual acuity affection, there is a significant difference in 
favor of endoscopic technology.
In our opinion, this difference is due to a 
number of objective and subjective factors. Endoscopic 
technology, although two-dimensional, provides the 
full panorama of a well-lit field of vision in the sella 
itself, supra and partially antero-sellarly, with a clear 
view of the chiasm, as well as optic nerves securely 
decompressed by radical resection, with preservation 
of the arachnoid and their anatomic CSF cisterns, 
documented with post-operative MRI which is only 
partially possible or not at all possible with microscopic 
technology. This option is certainly a result of technical 
progress as well as continuous training of the team 
itself, with growing agility, security, reliability, and 
expertise.
Conclusion
The results of our study, comparing 
the endoscopic versus microscopic transnasal, 
transsphenoidal resection of pituitary adenomas, have 
unequivocally shown that the endoscopic transnasal 
transsphenoidal procedure is a rational, effective, 
efficient, and above all safe technique, with numerous 
favorable advantages that allow for a higher degree of 
radicality.
Safe radical resection – gross total resection 
is the primary goal of every surgical oncologist, 
including this procedure, by providing neoplasm 
resection, preventing recurrence, and minimizing 
complications, thereby reducing/eliminating residuals, 
prolonging the grace period, i.e., tumor-free interval, 
better endocrinological, ophthalmologic and oncologic 
results, reduction of hospital days of patient stay, 
reduction of frequency and hazard of intra- and post-
operative complications, and crucial to improve the 
general and specific quality of life of patients. These are 
inevitable factors for the promotion and establishment 
of endoscopic transsphenoidal resection of pituitary 
adenomas in the future as a possible gold standard in 
the treatment of these lesions.
Certainly, nowadays, both technologies still 
have their place in the treatment of pituitary adenomas, 
but the technological evolution of optical equipment, and 
in symbiosis with continuous education and training of 
pituitary surgeons, will inevitably become a new global 
standard in the treatment of pituitary adenomas.
It is undisputed that this complex procedure 
is possible only as team collaboration with an 
endocrinologist, ophthalmologist, otorhinolaryngologist, 
neuroradiologist, anesthesiologist, oncologist, and as 
a long-term, comprehensive, and complex process of 
treating patients.
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